DUSP22 and anaplastic large cell lymphoma: MYC rearrangement has been rarely reported in ALK-negative ALCL with 2 patients recently described by Khanlari et al. both of whom had aggressive disease although one demonstrated a concurrent DUSP22 rearrangement and had longer survival compared to the patient without the alteration [12].